Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial.

Stefan SiebertArthur G PrattDeborah D StockenMiranda MortonAmy CranstonMichael ColeSheelagh FrameChristopher D BuckleyWan-Fai NgAndrew FilerIain B McInnesJohn D Isaacs

Published in: Medicine (2020)

ISRCTN, ISRCTN36667085. Registered on September 26, 2014; http://www.isrctn.com/ISRCTN36667085Current protocol version: Protocol version 11.0 (March 21, 2019).

Keyphrases

rheumatoid arthritis
randomized controlled trial
psychometric properties
disease activity
ankylosing spondylitis
systemic lupus erythematosus
interstitial lung disease
protein kinase
signaling pathway
wound healing